(2-hydroxypropyl) -alpha-cyclodextrin Solution 10% (w/v)

<strong>(2-hydroxypropyl)-alpha-cyclodextrin Solution 10% (w/v)</strong>_x000D_ <strong>Catalog number:</strong> K1010005B_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> 10% (w/v)_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> versatile tools in molecular assemblies, enhancement of solubility and organic synthesis_x000D_ <strong>Storage:</strong> 2-8¬∞C_x000D_ <strong>Keywords:</strong> HPŒ±CD, Œ±‚ÄêHPCD, 2‚Äêhydroxypropyl‚Äꌱ‚ÄêCD, HP-Œ±-CD, 2OHpŒ±CD, (2-hydroxypropyl)-a-cyclodextrin_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hoque S, Kondo Y, Sakata N, Yamada Y, Fukaura M, Higashi T, Motoyama K, Arima_x000D_ H, Higaki K, Hayashi A, Komiya T, Ishitsuka Y, Irie T. Differential Effects of_x000D_ 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in <i>Npc1</i>-Null Cells._x000D_ Int J Mol Sci. 2020 Jan 30;21(3):898._x000D_ _x000D_ 2: Tomono K, Goto H, Suzuki T, Ueda H, Nagai T, Watanabe J. Interaction of_x000D_ iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity._x000D_ Drug Dev Ind Pharm. 2002 Nov;28(10):1303-9._x000D_ _x000D_ 3: Motoyama K, Hashimoto Y, Hirayama F, Uekama K, Arima H. Inhibitory effects of_x000D_ 2,6-di-O-methyl-alpha-cyclodextrin on poly I:C signaling in macrophages. Eur J_x000D_ Pharm Sci. 2009 Feb 15;36(2-3):285-91._x000D_ _x000D_ 4: Holm R, Sch√∂nbeck C, Askj√¶r S, Jensen H, Westh P, √òstergaard J. Complexation_x000D_ of tauro- and glyco-conjugated bile salts with Œ±-cyclodextrin and hydroxypropyl-_x000D_ ��±-cyclodextrin studied by affinity capillary electrophoresis and molecular_x000D_ modelling. J Sep Sci. 2011 Nov;34(22):3221-30._x000D_ _x000D_ 5: Zarzycki PK, Ohta H, Saito Y, Jinno K. Interaction of native alpha-_x000D_ cyclodextrin, beta-cyclodextrin and gamma-cyclodextrin and their hydroxypropyl_x000D_ derivatives with selected organic low molecular mass compounds at elevated and_x000D_ subambient temperature under RP-HPLC conditions. Anal Bioanal Chem. 2008_x000D_ Aug;391(8):2793-801._x000D_ _x000D_ 6: Liu B, Li W, Nguyen TA, Zhao J. Empirical, thermodynamic and quantum-chemical_x000D_ investigations of inclusion complexation between flavanones and_x000D_ (2-hydroxypropyl)-cyclodextrins. Food Chem. 2012 Sep 15;134(2):926-32._x000D_ _x000D_ 7: Terekhova IV, Scriba GK. Study on complex formation of biologically active_x000D_ pyridine derivatives with cyclodextrins by capillary electrophoresis. J Pharm_x000D_ Biomed Anal. 2007 Nov 30;45(4):688-93._x000D_ _x000D_ 8: Rizzi V, Matera S, Semeraro P, Fini P, Cosma P. Interactions between_x000D_ 4-thiothymidine and water-soluble cyclodextrins: Evidence for supramolecular_x000D_ structures in aqueous solutions. Beilstein J Org Chem. 2016 Mar 21;12:549-63._x000D_ _x000D_ 9: Warne LN, Beths T, Whittem T, Carter JE, Bauquier SH. A review of the_x000D_ pharmacology and clinical application of alfaxalone in cats. Vet J. 2015_x000D_ Feb;203(2):141-8._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/10571279/">10: Kimura K, Hirayama F, Arima H, Uekama K. Solid-state 13C nuclear magnetic_x000D_ resonance spectroscopic study on amorphous solid complexes of tolbutamide with_x000D_ 2-hydroxypropyl-alpha- and -beta-cyclodextrins. Pharm Res. 1999_x000D_ Nov;16(11):1729-34. </a>_x000D_ _x000D_ <strong>Products Related to (2-hydroxypropyl)-alpha-cyclodextrin Solution 10% (w/v)</strong><a href="https://moleculardepot.com/product-category/Chemicals/">: Chemicals</a>